Target Audience
This activity has been designed to meet the educational needs of primary care physicians, nurse practitioners, physician assistants, and registered nurses involved in the management of patients with insomnia.
Estimated time to complete activity: 1.0 hour.
Physician Continuing Medical Education
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and MedEdicus. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
Credit Designation
This educational activity for 1.0 contact hour is provided by Postgraduate Institute for Medicine.
Accreditation Statement
Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Ruth Benca, MD, PhD, had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant Fees: Janssen Pharmaceuticals, Inc; Jazz Pharmaceuticals, Inc; Merck & Co, Inc. Contracted Research: Merck & Co, Inc.
Larry Culpepper, MD, MPH, had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant Fees: Astra Zeneca; Forest Labs; Lundbeck A/S; Merck & Co, Inc; Shire PLC, Inc; Takeda Pharmaceuticals Inc. Fees for Non-CME/CE Services Received Directly from a Commercial Interest or their Agents (e.g., speakers' bureaus): Elsevier Press. Ownership Interest: M‑3 Information, LLC. Royalty: UpToDate, Oxford University Press. Other: Editor in Chief of the Primary Care Companion for CNS Disorders.
Angela Golden, DNP, FNP-C, FAANP, had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant Fees: Merck & Co, Inc.
Planners and Managers Disclosures
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
The following PIM planners and managers, Trace Hutchison, PharmD; Samantha Mattiucci, PharmD, CHCP; Judi Smelker-Mitchek, RN, BSN; and Jan Schultz, RN, MSN, CHCP, and the following MedEdicus editors and planners, Cheryl Guttman and Cynthia Tornallyay, RD, MBA, CHCP, hereby state that they or their spouse/life partner did not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
Method of Participation and Request for Credit
There are no fees for participating in and receiving CME/CE credit for this activity. During the period of September 29, 2015, through September 29, 2016, participants must read the learning objectives and faculty disclosures and study the educational activity. Upon successfully completing the post-test with a score of 75% or better and the activity evaluation, your certificate will be made available immediately.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.